Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study (Q39420151)

11 September 2017

Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study (English)

1 reference

11 September 2017

0 references

Attebo K

1

1 reference

PubMed ID

8600410

11 September 2017

Mitchell P

series ordinal

2

1 reference

PubMed ID

8600410

11 September 2017

Smith W

series ordinal

3

1 reference

11 September 2017

1 March 1996

1 reference

11 September 2017

1 reference

11 September 2017

103

1 reference

11 September 2017

357-364

1 reference

11 September 2017

3

1 reference

Blindness in New South Wales. An estimate of the prevalence and some of the contributing causes

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Causes of blindness in Australia: analysis of pensions granted by the Department of Social Security on the ground of blindness for the year ending 30 June 1984.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

The Beaver Dam Eye Study: visual acuity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Blindness and visual impairment in an American urban population. The Baltimore Eye Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Physiological factors associated with falls in older community-dwelling women

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Visual problems in the elderly population and implications for services

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Resiliency as it affects treatment for refractive errors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Reducing vision loss in the community: a public health priority

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Effectiveness of a pinhole method for visual acuity screening

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Lessons from the Visual Acuity Impairment Survey pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

The Framingham Eye Study. I. Outline and major prevalence findings

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Functional blindness and visual impairment in older adults from three communities

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Visual impairment in a rural Appalachian community. Prevalence and causes.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Comparison of different screening methods for the detection of visual field defects in early glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Racial differences in the cause-specific prevalence of blindness in east Baltimore

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

Blind and partial sight registration in Avon

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930684-2

7 January 2021

10.1016/S0161-6420(96)30684-2

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

8600410